Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

October 22, 2008

RXi Creates New Position, Hires Khvorova

Worcester-based RXi Pharmaceuticals Corp. has named Anastasia Khvorova as Chief Scientific Officer, a newly created position for the company.

Khvorova previously held the same position at Dharmacon Inc., a division of Thermo Fisher Scientific and a developer and supplier of RNAi compounds. Before joining Dharmacon, she was a research scientist at Amgen, where she worked on the development of RNAi technology.

RNAi, which was pioneered by RXi co-founder, UMass Medical School professor and Nobel Prize winner Craig Mello, intends to treat diseases by interfering with the genes suspected of causing those diseases.

Sign up for Enews

WBJ Web Partners

0 Comments

Order a PDF